Published in Arch Gen Psychiatry on June 01, 2003
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry (2011) 3.53
Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci (2009) 2.55
Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging (2009) 2.14
Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry (2007) 2.13
Statistical analysis of longitudinal neuroimage data with Linear Mixed Effects models. Neuroimage (2012) 2.11
Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res (2009) 1.98
Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry (2013) 1.89
Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull (2009) 1.85
White matter microstructure in schizophrenia: effects of disorder, duration and medication. Br J Psychiatry (2009) 1.66
Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr Bull (2007) 1.59
Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry (2011) 1.56
Molecular profiles of schizophrenia in the CNS at different stages of illness. Brain Res (2008) 1.46
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46
Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev (2013) 1.40
Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry (2007) 1.40
Deconstructing psychosis with human brain imaging. Schizophr Bull (2007) 1.35
Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry (2007) 1.33
Neurocognition: clinical and functional outcomes in schizophrenia. Can J Psychiatry (2014) 1.32
The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophr Bull (2008) 1.30
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry (2012) 1.29
Cortical brain development in schizophrenia: insights from neuroimaging studies in childhood-onset schizophrenia. Schizophr Bull (2007) 1.27
What we know: findings that every theory of schizophrenia should explain. Schizophr Bull (2009) 1.27
Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study. Schizophr Bull (2009) 1.25
Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry (2008) 1.24
The myth of schizophrenia as a progressive brain disease. Schizophr Bull (2012) 1.21
Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb Cortex (2008) 1.20
Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia. Biol Psychiatry (2008) 1.19
Gamma oscillation deficits and the onset and early progression of schizophrenia. Harv Rev Psychiatry (2010) 1.17
Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. Schizophr Bull (2010) 1.13
Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. Handb Exp Pharmacol (2012) 1.12
Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"? Schizophr Bull (2008) 1.12
In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res (2009) 1.12
Spatiotemporal linear mixed effects modeling for the mass-univariate analysis of longitudinal neuroimage data. Neuroimage (2013) 1.11
Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry (2005) 1.10
Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. Am J Psychiatry (2006) 1.10
A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage (2007) 1.09
The lifetime trajectory of schizophrenia and the concept of neurodevelopment. Dialogues Clin Neurosci (2010) 1.08
Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol (2008) 1.06
Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment (2011) 1.06
Very poor outcome schizophrenia: clinical and neuroimaging aspects. Int Rev Psychiatry (2007) 1.04
Auditory Oddball fMRI in Schizophrenia: Association of Negative Symptoms with Regional Hypoactivation to Novel Distractors. Brain Imaging Behav (2008) 1.02
Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia. Schizophr Res (2012) 1.01
Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness. Schizophr Bull (2008) 0.99
Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci (2010) 0.99
Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory. Schizophr Res (2011) 0.99
Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia. Schizophr Bull (2007) 0.98
Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: differential sensitivity of clinical neuropsychological and experimental information processing tests. Schizophr Res (2007) 0.96
White matter neuron alterations in schizophrenia and related disorders. Int J Dev Neurosci (2010) 0.94
Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res (2007) 0.94
Cerebellum volume and eyeblink conditioning in schizophrenia. Psychiatry Res (2008) 0.94
Understanding structural brain changes in schizophrenia. Dialogues Clin Neurosci (2006) 0.93
Adjusting brain dynamics in schizophrenia by means of perceptual and cognitive training. PLoS One (2012) 0.93
Neurocognitive and neuroimaging predictors of clinical outcome in bipolar disorder. Curr Psychiatry Rep (2010) 0.92
Clinical prediction from structural brain MRI scans: a large-scale empirical study. Neuroinformatics (2015) 0.92
Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss. Neuroimage (2009) 0.90
Cingulate white matter neurons in schizophrenia and bipolar disorder. Biol Psychiatry (2009) 0.90
Progression of brain volume changes in adolescent-onset psychosis. Schizophr Bull (2008) 0.90
Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention. Neuropsychol Rev (2009) 0.89
Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia. Schizophr Res (2010) 0.89
Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage. Schizophr Bull (2014) 0.88
Delusions in individuals with schizophrenia: factor structure, clinical correlates, and putative neurobiology. Psychopathology (2005) 0.88
Altered interhemispheric and temporal lobe white matter microstructural organization in severe chronic schizophrenia. Neuropsychopharmacology (2013) 0.88
Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia. Ann Gen Psychiatry (2008) 0.87
The potential role of lamotrigine in schizophrenia. Psychopharmacology (Berl) (2005) 0.87
Brain gray matter phenotypes across the psychosis dimension. Psychiatry Res (2012) 0.87
Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia. BMC Genomics (2008) 0.86
BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. Adolesc Psychiatry (2005) 0.86
Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophr Res (2012) 0.86
Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis. BMC Psychiatry (2013) 0.86
Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia. Eur Arch Psychiatry Clin Neurosci (2005) 0.85
Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons. Schizophr Res Treatment (2012) 0.85
Reduced context effects on retrieval in first-episode schizophrenia. PLoS One (2010) 0.84
EARLY DETECTION AND INTERVENTION FOR PSYCHOSIS: PERSPECTIVES FROM NORTH AMERICA. Clin Neuropsychiatry (2008) 0.84
Progressive pathology is functionally linked to the domains of language and emotion: meta-analysis of brain structure changes in schizophrenia patients. Eur Arch Psychiatry Clin Neurosci (2011) 0.84
Age-related increase in the number of oligodendrocytes is dysregulated in schizophrenia and mood disorders. Schizophr Res Treatment (2011) 0.84
In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia. Neurobiol Dis (2014) 0.84
[Not Available]. Open Neuroimag J (2009) 0.83
Spared and impaired aspects of motivated cognitive control in schizophrenia. J Abnorm Psychol (2013) 0.83
Cerebral white matter abnormalities and their associations with negative but not positive symptoms of schizophrenia. Psychiatry Res (2014) 0.82
White matter integrity, language, and childhood onset schizophrenia. Schizophr Res (2012) 0.82
Brain imaging during the transition from psychosis prodrome to schizophrenia. J Nerv Ment Dis (2015) 0.82
Study factors influencing ventricular enlargement in schizophrenia: a 20 year follow-up meta-analysis. Neuroimage (2011) 0.82
Subgenual cingulate theta activity predicts treatment response of repetitive transcranial magnetic stimulation in participants with vascular depression. J Neuropsychiatry Clin Neurosci (2010) 0.81
G72 influences longitudinal change in frontal lobe volume in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2010) 0.81
Cortical grey matter and subcortical white matter brain microstructural changes in schizophrenia are localised and age independent: a case-control diffusion tensor imaging study. PLoS One (2013) 0.81
Effects of eye dominance (left vs. right) and cannabis use on intermanual coordination and negative symptoms in schizophrenia patients. Eur Arch Psychiatry Clin Neurosci (2014) 0.81
Aging effects on regional brain structural changes in schizophrenia. Schizophr Bull (2011) 0.80
Intact relational memory and normal hippocampal structure in the early stage of psychosis. Biol Psychiatry (2011) 0.80
Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. Mol Psychiatry (2011) 0.80
Gene x environment interactions in schizophrenia and bipolar disorder: evidence from neuroimaging. Front Psychiatry (2013) 0.80
The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects. Harv Rev Psychiatry (2016) 0.79
Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review. Curr Neuropharmacol (2015) 0.79
Psychotic symptoms and gray matter deficits in clinical pediatric populations. Schizophr Res (2012) 0.79
Dorsolateral prefrontal lobe volume and neurological soft signs as predictors of clinical social and functional outcome in schizophrenia: A longitudinal study. Indian J Psychiatry (2013) 0.79
Decreased bilateral thalamic gray matter volume in first-episode schizophrenia with prominent hallucinatory symptoms: A volumetric MRI study. Sci Rep (2015) 0.79
Conceptualization and treatment of negative symptoms in schizophrenia. World J Psychiatry (2015) 0.78
Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis. Psychol Med (2014) 0.78
Neuroimaging of schizophrenia: structural abnormalities and pathophysiological implications. Neuropsychiatr Dis Treat (2005) 0.78
Neuroanatomical Differences between First-Episode Psychosis Patients with and without Neurocognitive Deficit: A 3-Year Longitudinal Study. Front Psychiatry (2013) 0.78
CSF sub-compartments in relation to plasma osmolality in healthy controls and in patients with first episode schizophrenia. Psychiatry Res (2007) 0.78
Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA (2008) 5.96
Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol Psychiatry (2009) 4.44
Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph (2002) 4.19
Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up. Am J Psychiatry (2008) 3.72
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry (2011) 3.53
Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry (2003) 3.41
Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry (2005) 2.86
Capacity to provide informed consent for participation in schizophrenia and HIV research. Am J Psychiatry (2002) 2.41
Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects. Stat Med (2006) 2.35
Registration and machine learning-based automated segmentation of subcortical and cerebellar brain structures. Neuroimage (2007) 2.31
Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry (2002) 2.30
Abnormal brain structure in children with isolated clefts of the lip or palate. Arch Pediatr Adolesc Med (2007) 2.29
Brain structure in preclinical Huntington's disease. Biol Psychiatry (2005) 2.05
Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia. Am J Psychiatry (2006) 2.01
Involving Medical Students in Informed Consent: A Pilot Study. World J Surg (2015) 1.97
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Major depression following traumatic brain injury. Arch Gen Psychiatry (2004) 1.88
Coercion and informed consent in research involving prisoners. Compr Psychiatry (2003) 1.84
Frequency of mental and addictive disorders among 320 men and women entering the Iowa prison system: use of the MINI-Plus. J Am Acad Psychiatry Law (2008) 1.76
Gyrification abnormalities in childhood- and adolescent-onset schizophrenia. Biol Psychiatry (2003) 1.73
Short-term practice effects in amnestic mild cognitive impairment: implications for diagnosis and treatment. Int Psychogeriatr (2008) 1.64
Measures of growth in children at risk for Huntington disease. Neurology (2012) 1.59
Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry (2006) 1.59
Concurrent tracking of alcohol use and bipolar disorder symptoms. Bipolar Disord (2006) 1.58
Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry (2011) 1.56
Structural brain abnormalities in adult males with clefts of the lip and/or palate. Genet Med (2002) 1.55
Proton echo-planar spectroscopic imaging of J-coupled resonances in human brain at 3 and 4 Tesla. Magn Reson Med (2007) 1.53
Fully automated analysis using BRAINS: AutoWorkup. Neuroimage (2010) 1.52
Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. J Clin Psychiatry (2012) 1.48
Effects of unilateral clefts on brain structure. Arch Pediatr Adolesc Med (2010) 1.46
The prevalence of postpartum depression: the relative significance of three social status indices. Soc Psychiatry Psychiatr Epidemiol (2007) 1.43
Increased risk of alcohol and drug use among children from deployed military families. Addiction (2013) 1.42
Subgenual prefrontal cortex volumes in major depressive disorder and schizophrenia: diagnostic specificity and prognostic implications. Am J Psychiatry (2005) 1.41
The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science (2003) 1.40
Impulsivity across the course of bipolar disorder. Bipolar Disord (2010) 1.38
Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry (2003) 1.37
Investigation of relationships between fMRI brain networks in the spectral domain using ICA and Granger causality reveals distinct differences between schizophrenia patients and healthy controls. Neuroimage (2009) 1.37
Manual and semiautomated measurement of cerebellar subregions on MR images. Neuroimage (2002) 1.37
Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry (2007) 1.36
A Review of Challenges in the Use of fMRI for Disease Classification / Characterization and A Projection Pursuit Application from Multi-site fMRI Schizophrenia Study. Brain Imaging Behav (2008) 1.33
Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry (2007) 1.33
Morphology of the cerebral cortex in preclinical Huntington's disease. Am J Psychiatry (2007) 1.32
MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met. Proc Natl Acad Sci U S A (2008) 1.30
Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology (2002) 1.29
The neurodevelopmental impact of childhood-onset temporal lobe epilepsy on brain structure and function. Epilepsia (2002) 1.28
Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study. Schizophr Bull (2009) 1.25
Anterior cingulate cortex: an MRI-based parcellation method. Neuroimage (2006) 1.22
Older offenders, substance abuse, and treatment. Am J Geriatr Psychiatry (2002) 1.20
Cerebellar dysfunction in neuroleptic naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biol Psychiatry (2004) 1.20
Evaluation of the GTRACT diffusion tensor tractography algorithm: a validation and reliability study. Neuroimage (2006) 1.20
Brain volumes and surface morphology in monozygotic twins. Cereb Cortex (2002) 1.20
Impulsive and callous traits are more strongly associated with delinquent behavior in higher risk neighborhoods among boys and girls. J Abnorm Psychol (2008) 1.19
Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav (2002) 1.17
Visualizing how one brain understands another: a PET study of theory of mind. Am J Psychiatry (2003) 1.16
Positive alcohol expectancies partially mediate the relation between delinquent behavior and alcohol use: generalizability across age, sex, and race in a cohort of 85,000 Iowa schoolchildren. Psychol Addict Behav (2007) 1.15
Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry (2002) 1.14
Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Res (2005) 1.14
The MCIC collection: a shared repository of multi-modal, multi-site brain image data from a clinical investigation of schizophrenia. Neuroinformatics (2013) 1.14
Informed consent in medication-free schizophrenia research. Am J Psychiatry (2005) 1.12
Practice effects predict cognitive outcome in amnestic mild cognitive impairment. Am J Geriatr Psychiatry (2011) 1.11
Stereotyping and the treatment of missing data for drug and alcohol clinical trials. Subst Abuse Treat Prev Policy (2009) 1.11
Estimating premorbid functioning in huntington's disease: the relationship between disease progression and the wide range achievement test reading subtest. Arch Clin Neuropsychol (2010) 1.11
Cognitive dysfunction in adult males with non-syndromic clefts of the lip and/or palate. Neuropsychologia (2002) 1.10
Validity of symptom assessment in psychotic disorders: information variance across different sources of history. Schizophr Res (2004) 1.10
Neuropsychological functioning in children with non-syndromic cleft of the lip and/or palate. Child Neuropsychol (2009) 1.09
Brain tissue volume segmentation in patients with anorexia nervosa before and after weight normalization. Int J Eat Disord (2003) 1.07
Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Hum Brain Mapp (2012) 1.07
Right ventromedial prefrontal cortex: a neuroanatomical correlate of impulse control in boys. Soc Cogn Affect Neurosci (2008) 1.06
Use of the Mini International Neuropsychiatric Interview (MINI) as a screening tool in prisons: results of a preliminary study. J Am Acad Psychiatry Law (2004) 1.05
Rostral anterior cingulate cortex volume correlates with depressed mood in normal healthy children. Biol Psychiatry (2007) 1.05
Using a brief intervention to improve decisional capacity in schizophrenia research. Schizophr Bull (2005) 1.05
Neuropsychological performance is associated with vascular function in patients with atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol (2006) 1.05
Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry (2003) 1.05
Barriers to care for antenatal depression. Psychiatr Serv (2008) 1.05
The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states. Biol Psychiatry (2002) 1.04
Biological and environmental predictors of behavioral sequelae in children born preterm. Pediatrics (2009) 1.04
Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. J Clin Psychopharmacol (2007) 1.04
Amygdala volume correlates positively with fearfulness in normal healthy girls. Soc Cogn Affect Neurosci (2010) 1.03
Manual and automated measurement of the whole thalamus and mediodorsal nucleus using magnetic resonance imaging. Neuroimage (2002) 1.02
Hippocampal volume and mood disorders after traumatic brain injury. Biol Psychiatry (2006) 1.02
Association between the serotonin transporter promoter polymorphism (5-HTTLPR) and adult unresolved attachment. Dev Psychol (2009) 1.02
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. Schizophr Res (2011) 1.01